AmCham Slovakia

Investing in Healthcare and Biotech in Slovakia and CEE

Investing in Healthcare and Biotech in Slovakia and CEE

Thursday, Jan 23, 2025 From 09:00 to 12:00

Jurkovičova Tepláreň, Bottova 1, Bratislava

Business Breakfast

SPONSORED BY:




Investing in Healthcare and Biotech in Slovakia and CEE: Aligning with Draghi's Vision for European Competitiveness


Join us for a compelling event that delves into the dynamic landscape of healthcare and biotechnology investments in Slovakia and the CEE region. The event will feature a comprehensive presentation followed by an engaging panel discussion with industry experts, exploring the current investment trends, opportunities, and challenges within the sector.

We will also highlight key insights from Mario Draghi's report on strengthening European competitiveness, discussing how these strategies can foster growth and innovation in healthcare and biotech. The event will also include a presentation of the HICEE project which addresses the investment gap in CEE and fosters networking with investors in more developed investment healthcare and biotech ecosystems. A central theme will focus on strengthening the connection between the CEE region and the additional capital required for growth—building bridges to international investors and attracting experienced global talent to support a "reverse brain drain" effect.

Key issues, such as financing, creating incentives, and enhancing cooperation across public, private, and academic sectors, will be addressed, providing actionable insights for investors, policymakers, and stakeholders.

Don’t miss the opportunity to network with local stakeholders in this rapidly evolving field.


AGENDA

8:30 - Registration

9:00 - Opening

9:10 - Europe's competitiveness stands or falls on private capital – Report by Mario Draghi, former President of the European Central Bank



9:30 - Are investment opportunities in Health in CEE attractive?



9:45 - Coffee Break


10:05 - Investments in Biotech and Healthcare in CEE: The role of private capital and rntrepreneurs in the healthcare sector

Why do biotechnology companies and healthcare need private capital? With low public spending on innovation, there is an opportunity for private investors. How can this situation be leveraged to their advantage? You will discover how businesses, the public sector, investors, and investment funds approach this issue.



11:00 - Networking



Don’t miss the opportunity to network with local stakeholders in this rapidly evolving field.


Language: English

Documents to download

April 15, 2025

Connection Magazine Report

Format: .pdf, size: 0.48MB

download

Upcoming Events

19
Jun
How to Automate the Consolidated Financial Statement Process? online webinar organized by EY
General Assembly 2025
19
Jun
General Assembly 2025 Be the first to hear about AmCham achievements and activities in 2024.
Summer Innovation Business Cocktail
19
Jun
Summer Innovation Business Cocktail in Bratislava
20
Jun
Organizational culture and DEI organized by Develor Slovakia
24
Jun
HR Breakfast: Introduction to Immigration organized by Pro Relocation
European Health Data Space
26
Jun
European Health Data Space Business Seminar
30
04
Jun
Jul
ESSAI 2025 European Summer School on Artificial Intelligence
ESG in Transition: Staying Ahead in a Changing World
23
Sep
ESG in Transition: Staying Ahead in a Changing World